Skip to main content
Equibles
PRAX logo

PRAX · Praxis Precision Medicines, Inc. · Earnings Call Transcripts & Audio

Track PRAX — free

Use PRAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$291.23 +10.23 (+3.64%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$7.84B
Shares
27.92M
Volume · Sep 30 710.56K Avg daily vol (3M) 408.39K

Praxis Precision Medicines, Inc. Earnings Call Transcripts

Quarterly earnings calls for Praxis Precision Medicines, Inc. (PRAX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$68.72M '22 Q1 22-05-09 ▼54.3% $357,000 −$32.68M '24 Q2 24-08-13 ▼35.5% $302,000 −$51.91M '24 Q3 24-11-06 ▼100% $ −$71.13M '25 Q2 25-08-04 ▼100% $ −$73.93M '25 Q3 25-11-24 LATEST ▼100% $ −$88.91M '25 Q4 26-02-19
Earnings call
FY26 · Q2
2026-08-06
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript
Confident tone Commercial launch readiness Ulexacaltamide (Essential Tremor) NDA Relutrogene (SCN2A/8A) NDA and PDUFA
Diluted EPS
$-2.87
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Praxis Precision Medicines, Inc. (PRAX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-08
Praxis Precision Medicines, Inc. (PRAX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript
Confident tone Vormatrigene (POWER 1/2/3) program Uliexacaltamide for Essential Tremor Emerald broad DE study enrollment
Diluted EPS
$-3.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Praxis Precision Medicines, Inc. (PRAX) Q4 2025 Earnings Call Transcript
Confident tone Relutrigine in DEEs Ulixacaltamide in essential tremor Regulatory and FDA interactions
Revenue
$*
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-24
Praxis Precision Medicines, Inc. (PRAX) Q3 2025 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-3.36
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Praxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call Transcript
Confident tone RADIANT study efficacy results Pipeline and upcoming catalysts Safety and tolerability profile
Revenue
$
▼ 100% YoY
Diluted EPS
$-3.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-06
Praxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call Transcript
Confident tone Ulixacaltamide Phase 3 Essential Tremor Program Relutrigine in SCN2A and SCN8A DEEs Vormatrigine (PRAX-628) ENERGY Program in Epilepsy
Revenue
$302,000
▼ 35.5% YoY
Diluted EPS
$-2.75
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings Call
Revenue
$357,000
▼ 54.3% YoY
Diluted EPS
$-1.74
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Praxis Precision Medicines, Inc. (PRAX) Q1 2022 Earnings Call Transcript
Revenue
$
Diluted EPS
$-22.65
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Praxis Precision Medicines, Inc. (PRAX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Praxis Precision Medicines, Inc. (PRAX) Q3 2021 Earnings Call Transcript
Diluted EPS
$-15.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-17
Praxis Precision Medicines, Inc. (PRAX) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 earnings calls
Key facts CIK 1689548 CUSIP 74006W207 13F (30d) 8 filings 8 filers Visit website Investor relations